a developer of targeted immunotherapies and vaccines to treat and prevent diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, RNAC has been closely correlated with PIRS. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then PIRS could also see price increases.
Ticker / NAME | Correlation To RNAC | 1D Price Change % | ||
---|---|---|---|---|
RNAC | 100% | -6.02% | ||
PIRS - RNAC | 94% Closely correlated | -5.16% | ||
WINT - RNAC | 94% Closely correlated | -60.67% | ||
NCNA - RNAC | 92% Closely correlated | -7.10% | ||
CDTX - RNAC | 92% Closely correlated | -2.52% | ||
NBY - RNAC | 91% Closely correlated | -0.43% | ||
More |
Ticker / NAME | Correlation To RNAC | 1D Price Change % |
---|---|---|
RNAC | 100% | -6.02% |
immunotherapy theme (13 stocks) | 64% Loosely correlated | -0.95% |
RNAC theme (22 stocks) | 46% Loosely correlated | -0.97% |
cancer theme (87 stocks) | 30% Poorly correlated | +0.89% |
vaccines theme (15 stocks) | 24% Poorly correlated | +1.51% |
diseases theme (42 stocks) | 23% Poorly correlated | +1.03% |
More |